U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 005264

Expand all

HEPARIN LOCK FLUSH (HEPARIN SODIUM)
100 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN LOCK FLUSH
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 100 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005264
Product Number: 010
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
HEPARIN SODIUM PRESERVATIVE FREE (HEPARIN SODIUM)
2,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM PRESERVATIVE FREE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005264
Product Number: 013
Approval Date: Apr 7, 1986
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
HEPARIN SODIUM PRESERVATIVE FREE (HEPARIN SODIUM)
2,500 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM PRESERVATIVE FREE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2,500 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005264
Product Number: 014
Approval Date: Apr 7, 1986
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
PANHEPRIN (HEPARIN SODIUM)
1,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: PANHEPRIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005264
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
PANHEPRIN (HEPARIN SODIUM)
5,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: PANHEPRIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005264
Product Number: 006
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
PANHEPRIN (HEPARIN SODIUM)
10,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: PANHEPRIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005264
Product Number: 007
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
PANHEPRIN (HEPARIN SODIUM)
20,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: PANHEPRIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005264
Product Number: 008
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
PANHEPRIN (HEPARIN SODIUM)
40,000 UNITS/ML
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: PANHEPRIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005264
Product Number: 009
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top